BioMarin Pharma (BMRN) Posts Q4 Loss of $0.53
Tweet
Share
E-mail
Get Alerts BMRN Hot Sheet
Price: $58.18 -1.37%
Revenue Growth %: +13.2%
Financial Fact:
Net product revenues: 278.26M
Today's EPS Names:
CRMT, PKE, More
Revenue Growth %: +13.2%
Financial Fact:
Net product revenues: 278.26M
Today's EPS Names:
CRMT, PKE, More
Join SI Premium – FREE
BioMarin Pharma (NASDAQ: BMRN) reported Q4 EPS of ($0.53), which may not compare to the analyst estimate of ($0.38). Revenue for the quarter came in at $300 million versus the consensus estimate of $295.96 million.
For earnings history and earnings-related data on BioMarin Pharma (BMRN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Piper Sandler defends Oracle ahead of earnings, sees $2.2 billion OCI upside
- KeyBanc: 'We Like AT&T (T) and TMUS'
- Franklin Covey (FC) Misses Q3 EPS by 2c, lowers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
